Veradigm (NASDAQ:MDRX) Shares Gap Up to $7.45

Veradigm Inc. (NASDAQ:MDRX)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $7.45, but opened at $7.90. Veradigm shares last traded at $7.90, with a volume of 11,746 shares changing hands.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on MDRX. Barclays began coverage on shares of Veradigm in a research report on Wednesday, January 3rd. They set an “equal weight” rating and a $11.00 price objective on the stock. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $10.00 price objective (down from $15.00) on shares of Veradigm in a research report on Tuesday, March 19th. StockNews.com assumed coverage on shares of Veradigm in a research report on Monday. They set a “hold” rating on the stock. Finally, Royal Bank of Canada reduced their target price on shares of Veradigm from $22.00 to $11.00 and set an “outperform” rating on the stock in a research report on Friday, January 19th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat.com, Veradigm has an average rating of “Hold” and a consensus target price of $11.25.

Veradigm Price Performance

The stock’s 50-day moving average price is $7.81 and its two-hundred day moving average price is $10.16.

Institutional Trading of Veradigm

Hedge funds and other institutional investors have recently modified their holdings of the business. Quarry LP bought a new position in Veradigm in the 1st quarter worth about $37,000. TFO Wealth Partners LLC boosted its stake in Veradigm by 105,280.0% in the 4th quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after purchasing an additional 5,264 shares in the last quarter. Gladius Capital Management LP boosted its stake in Veradigm by 135.0% in the 4th quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock worth $66,000 after purchasing an additional 3,587 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in Veradigm by 95.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,310 shares of the software maker’s stock worth $67,000 after purchasing an additional 2,587 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its stake in Veradigm by 27.4% in the 1st quarter. Envestnet Asset Management Inc. now owns 32,691 shares of the software maker’s stock worth $69,000 after purchasing an additional 7,027 shares in the last quarter.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.